Abiopharma

News list

Patel Paresh 🟢 acquired 5.0M shares (1 derivative) of Exzeo Group, Inc. (XZO) at $23.00 ($115.0M) Transaction Date: May 05, 2026 | Filing ID: 209014

Full text

News bot May 6, 2026, 8:16 p.m.
🔍 Patel Paresh (Executive)

Company: Exzeo Group, Inc. (XZO)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 2,000
- Total shares held: 5,000,000
Detailed Transactions and Holdings:
- Acquired 1,500 shares of Common Stock at $17.13 per share (Direct)
  Date: 2026-05-05 | Code: P | equity_swap_involved: false | shares_owned_after: 1,641,513.00 | transaction_form_type: 4
- Acquired 500 shares of Common Stock at $17.05 per share (Direct)
  Date: 2026-05-05 | Code: P | equity_swap_involved: false | shares_owned_after: 1,642,013.00 | transaction_form_type: 4
- Holds 5,000,000 shares of Stock Option (Right to Buy) at $23.0 per share (Derivative)
  Date: 2026-05-05 | Code: H | Expires: 2031-10-01 | shares_owned_after: 5,000,000.00 | Footnotes: F1
Footnotes:
- F1: On October 1, 2021, the reporting person was granted an option to purchase 5,000,000 shares of common stock. The option vested with respect to one fourth of the shares on October 1, 2022 and with respect to one sixteenth of the shares on each January 1, April 1, July 1 and October 1 thereafter.